<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02285400</url>
  </required_header>
  <id_info>
    <org_study_id>LY20140927</org_study_id>
    <nct_id>NCT02285400</nct_id>
  </id_info>
  <brief_title>Effects of CPAP Level on Respiratory Mechanics and Central Drive in Patients With COPD</brief_title>
  <official_title>Effects of Continuous Positive Airway Pressure (CPAP) Level on Respiratory Mechanics and Central Drive in Patients With Chronic Obstructive Pulmonary Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zhujiang Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Guangzhou Institute of Respiratory Disease</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Zhujiang Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Chronic Obstructive Pulmonary Disease (COPD) is a common respiratory disease characterized by&#xD;
      airflow limitation that is progressive and not fully reversible. Expiratory flow limitation&#xD;
      (EFL) is the main mechanism leading to dynamic pulmonary hyperinflation (DPH) and intrinsic&#xD;
      positive end-expiratory pressure (PEEPi). DPH and PEEPi lead to increased inspiratory muscle&#xD;
      efforts and impaired central drive mechanical and ventilation coupling, which is an important&#xD;
      mechanism of dyspnea. Appropriate setting of extrinsic PEEP (PEEPe) can decrease inspiratory&#xD;
      efforts and work of breathing, improve patient-ventilator synchrony in severe COPD patients&#xD;
      with PEEPi and treated with mechanical ventilation. Nevertheless, the effects of CPAP/PEEPe&#xD;
      level on respiratory mechanics, especially on central drive mechanical and ventilation&#xD;
      coupling, still need further investigations.&#xD;
&#xD;
      In the present study, about 40 patients with COPD will be recruited as research subjects. And&#xD;
      the investigators aim to observe the changes in respiratory mechanics, central drive&#xD;
      mechanics, central drive mechanical and ventilation coupling at different levels of CPAP.&#xD;
      Contrast analysis will be conducted to evaluate the effects of CPAP level on respiratory&#xD;
      mechanics and central drive during DPH, which may provide a reasonable basis for the clinical&#xD;
      application of CPAP to COPD patients and the exploration of a new reasonable CPAP setting&#xD;
      method.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with COPD are divided into two groups: moderate group and severe group, both of&#xD;
      which are intervented by CPAP level. The static pressure volume curves of the lung and chest&#xD;
      wall (Campbell diagram) were established with slow deep respiratory manoeuvre. Before using&#xD;
      CPAP level, we will measure the relevant parameters of lung volume, respiratory flow,&#xD;
      diaphragm electromyogram, central drive mechanical and ventilation coupling. Then incremental&#xD;
      CPAP level will be applied to investigate the effects of CPAP level on the above mentioned&#xD;
      respiratory mechanics parameters.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2014</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Diaphragmatic function</measure>
    <time_frame>Change from baseline in diaphragm electromyogram at 12 cmH2O CPAP level. (10 minutes later,20minutes later,30 minutes later, 40 minutes later)</time_frame>
    <description>Diaphragmatic function can be assessed by diaphragm electromyogram (EMGdi), which reflect the physiological activity of the diaphragm and indicate functional status of the central drive.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Respiratory pressure</measure>
    <time_frame>Chang from baseline in respiratory pressure at 12 cmH2O CPAP level.(10 minutes later,20minutes later,30 minutes later, 40 minutes later)</time_frame>
    <description>Respiratory pressure parameters include gastric pressure (Pga), esophageal pressure (Pes), transdiaphragmatic pressure ( Pdi), mouth pressure (Pmo).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiratory volume</measure>
    <time_frame>Chang from baseline in respiratory volume at 12 cmH2O CPAP level. (10 minutes later,20minutes later,30 minutes later, 40 minutes later)</time_frame>
    <description>Respiratory volume is associated with Flow, Inspiratory capacity (IC), tidal volume (VT), respiratory rate (RR), inspiratory time (Ti),expiratory time (Te), minute ventilation (VE).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Degree of dyspnea</measure>
    <time_frame>Chang from baseline in dyspnea at 12 cmH2O CPAP level. (10 minutes later,20minutes later,30 minutes later, 40 minutes later)</time_frame>
    <description>Difference in the degree of dyspnea can be measured by Borg index.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Pulse oxygen saturation (SpO2)</measure>
    <time_frame>Chang from baseline in SpO2 at 12 cmH2O CPAP level. (10 minutes later,20minutes later,30 minutes later, 40 minutes later)</time_frame>
    <description>Change in SpO2 can be recorded by noninvasive monitoring instruments.</description>
  </other_outcome>
  <other_outcome>
    <measure>End tidal carbon dioxide pressure (PETCO2)</measure>
    <time_frame>Chang from baseline in PETCO2 at 12 cmH2O CPAP level. (10 minutes later,20minutes later,30 minutes later, 40 minutes later)</time_frame>
    <description>Change in PETCO2 can be recorded by noninvasive monitoring instruments.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Chronic Obstructive Pulmonary Disease (COPD)</condition>
  <arm_group>
    <arm_group_label>Moderate COPD patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients are connected to the noninvasive ventilator and incremental CPAP level is performed.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Severe COPD patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients are connected to the noninvasive ventilator and incremental CPAP level is performed.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>CPAP level</intervention_name>
    <description>CPAP level ranges between 4 and 12 cm water column (cmH2O), each pressure increment for 1 cmH2O.</description>
    <arm_group_label>Moderate COPD patients</arm_group_label>
    <arm_group_label>Severe COPD patients</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients from Zhu jiang Hospital,Southern Medical University&#xD;
&#xD;
          -  Patients aged 40-70 years old&#xD;
&#xD;
          -  Patients with pulmonary function test of forced expiratory volume at one second&#xD;
             (FEV1)/forced vital capacity(FVC) &lt; 70% and 30% ≤ FEV1%pred &lt; 80%&#xD;
&#xD;
          -  Patients in a clinically stable state&#xD;
&#xD;
          -  Patients who signed informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with signs of an airway infection&#xD;
&#xD;
          -  Patients with an acute exacerbation during the previous 4 weeks&#xD;
&#xD;
          -  Patients with giant bulla(≥3cm in diameter)&#xD;
&#xD;
          -  Patients with recent upper abdominal surgery&#xD;
&#xD;
          -  Patients with one or more of the following diseases: esophageal cancer, reflux&#xD;
             esophagitis, severe obstructive sleep apnea (apnea hypopnea index&gt;15/hr),&#xD;
             neuromuscular disease, or significant heart failure&#xD;
&#xD;
          -  Patients with poor compliance.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xin Chen, Doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Zhujiang Hospital,Southern Medical Unversity</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Zhujiang Hospital,Southern Medical Universtiy</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510282</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>July 2015</verification_date>
  <study_first_submitted>October 11, 2014</study_first_submitted>
  <study_first_submitted_qc>November 6, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 7, 2014</study_first_posted>
  <last_update_submitted>December 29, 2015</last_update_submitted>
  <last_update_submitted_qc>December 29, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 31, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>COPD</keyword>
  <keyword>CPAP</keyword>
  <keyword>Central Drive</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

